Subclinical Gum Disease — Body Handbook

Mouth · §214

Subclinical Gum Disease

If your gums bleed when you brush or floss, you have early gum disease. About 42% of US adults aged 30 and up carry some form of it; the substantial majority have never been told. It doesn't hurt and doesn't look dramatic, but the chronic open wound inside your mouth feeds a low-grade fire that shows up in the rest of the body — higher cardiovascular risk, worse blood-sugar control in diabetics, a measurably elevated risk of dying earlier. The gingivitis stage reverses in about a week of doing the basics properly. Past that line, it gets harder to take back.

Do · Daily Evidence Moderate Chapter Mouth

The reward for catching this early is large and the work is small: five minutes of daily mouth-care plus two cleanings a year clears most of what the average adult is carrying. Diabetics get the biggest medical bonus — treating gum disease drops HbA_1c about as much as adding a second oral medication. The catch is the silence: there's no pain until late, so most people don't act until their dentist surprises them with the words "deep cleaning" at age 50. The fix is not heroic. It's a slightly better toothbrush, a daily habit you probably skipped today, and a willingness to take pink in the sink seriously.

Plaque is a bacterial biofilm that builds on tooth surfaces day by day. When it accumulates at the gumline — especially in the small gap between gum and tooth called the sulcus — the immune system reads it as a wound and sends blood vessels, fluid, and white blood cells into the area. That's gingivitis: the gums get red and puffy, they bleed easily, breath turns slightly sour. In a clean experiment from the 1960s, dental students stopped brushing for three weeks and reliably developed gingivitis; everyone got it, and everyone reversed it within a week of starting up again Loe et al. 1965. That's the easy stage.

In a subset of people, the bacterial community shifts. Specific Gram-negative anaerobes — Porphyromonas gingivalis is the headliner — colonize below the gumline and the inflammation goes from contained to destructive. The body starts eating its own bone away from the tooth as it tries to wall off the infection. Each tooth ends up sitting in a deeper and deeper pocket; the supporting fibers stretch and tear. This is periodontitis. By Stage III, teeth start to wiggle; by Stage IV, they come out. Whether you make this jump from gingivitis to periodontitis depends on smoking, blood sugar control, immune-system phenotype, and genes — not on biofilm volume alone.

The damage that reaches the rest of the body comes from a different fact: a moderate-periodontitis mouth has roughly the surface area of a palm in chronic ulcerated wound, lined with that dysbiotic biofilm. Three things leak out of it. Bacteria themselves cross into the bloodstream every time you brush, chew, or floss — oral organisms have been pulled from blood cultures within minutes of toothbrushing, and from the inside of atherosclerotic plaques on autopsy. Bacterial cell-wall fragments and pro-inflammatory cytokines like IL-6 and TNF-α spill into the circulation continuously, telling the liver to crank up CRP and the body's baseline inflammatory tone. And P. gingivalis in particular carries a unique enzyme that chemically modifies your own proteins in a way that may help kick off autoimmune reactions Wegner et al. 2010 Schenkein et al. 2020. The mouth is connected to the body. The body knows.

How big the problem actually is

The headline number from the most recent US national surveillance: 42% of adults aged 30 and over have some form of periodontitis when their gums are actually probed; 7.8% have the severe form. Add gingivitis on top — the bleeding-without-bone-loss version — and roughly half the adult population is walking around with active gum inflammation at any given moment Eke et al. 2018. The global picture is similar: severe periodontitis affects an estimated 11.2% of adults worldwide, making it the sixth most common chronic disease on the planet Kassebaum et al. 2014. Most of these adults have no idea. Adults who haven't seen a dentist in the past year carry periodontitis at rates above 54% Eke et al. 2018; nobody has measured their pocket depths, so the disease never gets named.

The systemic associations are some of the most replicated in modern medicine, with different evidence strengths for different organs.

The cleanest line is to the heart and to all-cause mortality. A 2021 systematic review pooled 11 prospective cohort studies (over 850,000 adults followed for years) and found a 22% higher rate of new cardiovascular disease in adults with periodontal disease vs. those without (relative risk 1.22; 95% CI 1.14–1.30) Larvin et al. 2021. A separate NHANES cohort of 15,030 adults followed for a median of 9 years found a 22% elevation in all-cause mortality, climbing to roughly 40% above baseline for severe periodontitis — with a clean dose-response across severity Larvin et al. 2024. The 2020 European-Cardiology consensus formalized the association as real, mechanism-plausible, and clinically relevant; it stopped short of declaring that treating gum disease prevents heart attacks because no adequately-powered randomized trial has tested it Sanz et al. 2020.

The diabetes connection is the one with actual randomized trials behind it. Multiple meta-analyses converge on an HbA_1c reduction of roughly 0.3 to 0.5 percentage points from professional periodontal treatment in diabetics — the same order of magnitude as adding a second oral glucose-lowering pill.

Pregnant women with periodontitis have roughly 1.8 times higher odds of preterm birth and of low-birthweight delivery in meta-analytic pooling Daalderop et al. 2018. Adults with severe periodontitis carry a 20–30% elevated risk of incident dementia over the following decade in long-term cohort studies Asher et al. 2022; the 2019 finding of P. gingivalis DNA and its toxic proteases inside Alzheimer's brains was the most provocative oral-systemic link of the last decade Dominy et al. 2019, though a Phase 2/3 trial of a drug targeting that bacterium failed its primary endpoint overall Detke et al. 2023. P. gingivalis's unique ability to modify human proteins in a way that may trigger autoimmunity is the cleanest hypothesis for the consistent periodontitis-rheumatoid-arthritis association Wegner et al. 2010. None of these endpoints have a randomized trial behind them. All of them have replicated observational signal and a plausible mechanistic story.

The honest read isn't that gum disease causes heart attacks, dementia, and rheumatoid arthritis in any individual case — the data don't support a confident causal claim at that level. It's that an entire population walking around with a chronic open wound and a low-grade systemic inflammatory load is paying a measurable price across multiple organ systems, and the people on the worse end of the gum-disease spectrum are paying the most.

What ignoring it costs you

Year one of subclinical disease is silence. You notice a pink streak in the sink some mornings; you brush a little softer. Your breath isn't quite right by mid-afternoon and you blame coffee. You look in the mirror and your gums look a little puffy where they meet the teeth, but you can't remember what they used to look like. Your dentist has been writing "mild gingivitis — recommend flossing" on your chart for years; the hygienist scrapes a bit harder at each visit. You float along.

Across five to ten years — for the susceptible third of adults — the disease quietly converts. The pockets deepen. The bone supporting your teeth recedes a millimeter or two and the gum line follows; your front teeth start looking longer than they used to in photos. You think it's just getting older. Your partner mentions that your breath has been bad in the morning lately. You catch yourself probing a wobbly molar with your tongue. The dentist uses the phrase "deep cleaning" for the first time. By then you are looking at a $1,000 procedure and the conversation has moved from prevention to damage control.

Past that, across two decades, the trajectory bends into the rest of the body. The same low-grade inflammation that's been smoldering in your mouth has been smoldering everywhere your blood reaches. If you're a diabetic, your sugars run higher than they should; your endocrinologist adds another medication and the next one and you blame compliance. If you have a family-history risk for heart disease, your decade-out cardiac risk has been ticking up a little faster than your bloodwork suggested it should — in the cohort of adults followed for nine years, severe untreated periodontitis ran a 40% higher all-cause mortality rate than periodontally-healthy controls of the same age Larvin et al. 2024. You will not feel that part. You will feel tired in your 60s and accept it as your 60s. If you're in the older half of adults, your risk of slipping into mild cognitive impairment over the next decade is meaningfully elevated and you may never connect that to the bleeding gums you ignored at 35 Asher et al. 2022.

None of this is dramatic in any single year. The trick of the disease, like most chronic-inflammation conditions, is that the felt cost in the moment is approximately zero and the cumulative cost across decades is large. You don't get warned. You just keep noticing the pink streak and looking the other way.

What actually works

Two pieces: a daily home routine and a professional checkpoint a couple of times a year. Both pieces have to happen. Skipping either one is most of how people lose this.

Brush twice a day, two minutes each time. Soft bristles, light pressure, all surfaces. The two-minute number isn't arbitrary — most people stop after 30 to 45 seconds and miss a third of their mouth.
An electric brush helps modestly. The rotating-oscillating type cuts plaque about 21% better and gingivitis about 11% better than manual brushing over the long run Yaacob et al. 2014. Not transformative, but the easiest win in the toolkit.
Clean between your teeth every day. Floss, interdental brushes (small bristled picks), or a water flosser. Pick whichever you'll actually do; interdental brushes are a touch more effective than floss for adults with gaps wide enough to take them Worthington et al. 2019.
Professional cleaning every six months. Three or four times yearly if you smoke, have diabetes, are pregnant, or have a history of periodontitis. Ask explicitly for a periodontal probing — the dentist measures the pocket depth around each tooth and writes down the number.
If you smoke, quit. About three-quarters of the periodontitis a current smoker carries is caused by the smoking; the risk drops back toward baseline about a decade after quitting Tomar et al. 2000.

The home routine is what gingivitis responds to. Done properly, it clears most cases inside two weeks — the bleeding stops, the redness fades, the gum margin tightens up against the tooth. That's not anecdote; it's the classical "experimental gingivitis" finding: stop brushing, get gingivitis on a clock; restart brushing, lose the gingivitis on a clock Loe et al. 1965. If yours doesn't respond inside three weeks of doing the routine properly, it's past the gingivitis stage and you need the professional version.

The professional version for established periodontitis is called scaling and root planing — the deep cleaning your dentist or hygienist did under local anesthesia. They mechanically remove the calcified plaque and bacterial film from the tooth surfaces below the gumline, where your brush cannot reach. The ADA's evidence-based guideline pooled 72 trials and found a typical improvement of about half a millimeter in gum attachment, with various adjuncts (locally-delivered antibiotics, mouthrinses, low-dose doxycycline) adding another 0.2 to 0.6 millimeters Smiley et al. 2015. Half a millimeter sounds small; in a periodontal pocket it's the difference between a tooth that survives the next decade and one that doesn't. After SRP you're not cured — the underlying tendency persists — but you have a clean baseline to maintain from.

One more piece for diabetics specifically. The diabetes/gum-disease loop runs both directions: high blood sugar makes gum disease worse, and gum disease makes blood sugar harder to control. Getting periodontal therapy done is one of the few non-medication moves that drops HbA_1c by a clinically meaningful amount — the 2018 trial saw a 0.6 point reduction sustained at a year, comparable to adding a second drug D'Aiuto et al. 2018. If you have type 2 diabetes and you haven't had a periodontal exam recently, this is one of the higher-leverage moves you have available.

What most people get wrong

"Bleeding gums mean I'm brushing too hard." Bleeding from normal brushing or flossing is the disease. Healthy gums do not bleed when you brush them; an inflamed, ulcerated sulcus does. The right response is more thorough cleaning, not less. If the bleeding doesn't clear inside two to three weeks of doing it properly, you're past gingivitis and need a hygienist.

"If it doesn't hurt, it's fine." Periodontitis is almost completely painless until late. The chronic version of the inflammation doesn't fire the nerve endings the same way an acute infection does. Most adults find out they have it from a pocket-depth probing exam, not from symptoms. Waiting until your gums hurt means waiting until you're past Stage III.

"Flossing doesn't actually work — even Cochrane said so." What Cochrane actually said: no high-quality long-term trial has measured whether flossing prevents periodontitis — because the trial that would settle it has never been run Worthington et al. 2019. The short-term trials they did review showed flossing does reduce gingivitis. And the bacteria that drive periodontitis live exactly in the spots between teeth that a brush bristle cannot reach. Absence of long-term trial evidence is not evidence the practice doesn't work.

"Brushing harder gets you cleaner." Hard brushing with hard bristles produces gum recession and tooth-surface wear without cleaning more effectively. Soft bristles, light pressure, two full minutes. Time beats force.

"Mouthwash can replace flossing." Antibacterial mouthwash kills surface bacteria but does not physically remove the established biofilm under the gumline. It's an add-on, not a substitute — and chronic chlorhexidine rinsing stains teeth and disrupts the oral microbiome over time.

"It's just my mouth." The cross-organ link — cardiovascular, diabetes, pregnancy outcomes, dementia, mortality — is one of the most replicated associations in adult medicine. Whether causal for any specific endpoint is still debated; whether the association is real and clinically meaningful is not Sanz et al. 2020.

Where this goes sideways

You wait for pain. The single biggest failure pattern. There is no pain signal at Stage I or II. Adults walk around with three or four millimeters of bone loss for years, then learn about it when a periodontist describes a treatment plan in the four-figure range. The only way out of this trap is to get probed at every dental visit and to act on the bleeding-on-brushing signal earlier.

You brush but you don't clean between. The interproximal contacts — the touching surfaces of adjacent teeth — are where periodontitis starts and where it does the most damage. A toothbrush bristle cannot reach there. Adults who brush twice a day for thirty years without flossing develop pristine-looking outer surfaces and bone loss between every tooth.

You stop going to the dentist. Cost, fear, schedule. The NHANES adults who hadn't been to the dentist in the prior year carried periodontitis at rates above 54% Eke et al. 2018. Pocket depths are not self-measurable. If nobody is probing your gums, the disease is invisible to you by design.

You get the deep cleaning and then go back to your old routine. Scaling and root planing buys you a clean baseline. Without daily mechanical cleaning, professional maintenance every three to four months, and the underlying risk factor (smoking, glycemic control) handled, the pockets re-colonize within six to twelve months and the bone loss resumes.

You keep smoking. Periodontal therapy in an active smoker is, honestly, largely palliative. Three-quarters of the periodontitis you carry as a current smoker is caused by the smoking itself Tomar et al. 2000; your gum tissue heals worse from any procedure, your immune response to the biofilm is blunted, and your trajectory keeps progressing even with good home care. If you're going to do one thing for your gums, quitting smoking is it.

What it costs and where you actually get this checked

The daily home setup is cheap. A soft-bristled toothbrush is a few dollars; floss runs about five dollars a year; interdental brushes twenty to forty dollars a year; a water flosser is a one-time fifty to one hundred dollars. A decent rotating-oscillating electric brush is thirty to two hundred dollars up front with replacement heads adding another twenty to forty dollars a year. Fluoride toothpaste is the cheap part. Total annual home-care cost: fifty to two hundred dollars on the high end.

The professional side is where insurance enters the picture. In the US, twice-yearly preventive cleanings are typically covered in full or with a small co-pay by dental insurance — a cleaning runs $75 to $200 cash. A periodontal probing-and-charting exam should be done at least once a year and should be in the chart; ask explicitly if you don't see it. Scaling and root planing for established periodontitis costs $200 to $400 per quadrant of the mouth, so a full four-quadrant treatment lands at $800 to $1,500; dental insurance usually pays 50 to 80% of perio therapy, but the annual benefit cap can be exhausted by a full-mouth treatment. Surgical periodontal procedures (flap surgery, bone grafting, guided tissue regeneration) run $1,000 to $3,000 per quadrant and are inconsistently covered.

The friction is rarely the money. Floss is essentially free. The friction is fitting the routine into a daily schedule and getting back into the chair on a cadence. For adults without dental insurance the right move is a community health center or a dental school clinic — both run preventive care at substantial discount.

What changes when you treat it

The first thing you notice is that the sink stays clean. Within five to seven days of brushing properly and cleaning between your teeth, the pink stops showing up. By week two the gums look different in the mirror — the puffy red margins shrink back to a tighter pale pink, the line where gum meets tooth crisps up. Your breath gets cleaner across the day; the people who live with you stop politely turning their faces. None of this is dramatic. It's the felt experience of an inflammatory wound resolving on the timeline the body is wired to do it on Loe et al. 1965.

If you had a deep cleaning done, the felt benefit ramps up across the first three months — less tenderness, less bleeding, the breath improvement that surprises you when you notice it. By six months the surrogate markers of the systemic inflammation have moved: CRP and IL-6 come down measurably; a measure of how well your arteries dilate to demand — the bridge to cardiovascular risk — improves Tonetti et al. 2007. You don't feel that part directly. The lab values feel it.

The diabetes payoff lands inside a year. For type 2 diabetics with moderate-to-severe gum disease, treating the gum disease drops HbA_1c by around half a percentage point sustained at twelve months — on the same order as adding another diabetes medication D'Aiuto et al. 2018. The endocrinologist won't mention your gums when she reads the new number; the dentist will.

The cardiovascular and dementia dividends compound across decades and you will probably never directly perceive them. The cohorts that have run the long arithmetic show people who maintained periodontal health tracking closer to the healthy curve, and people with severe untreated disease tracking a steadily worse one Larvin et al. 2024. You don't feel the years you didn't lose. You just keep waking up with clean gums, and one day a cardiologist looks at your numbers at 65 and tells you they look better than they should for someone your age. That's the part you bought without ever noticing.

Related, but not this entry

If your teeth are already loose, your gum line has visibly receded, or your dentist has used the phrase "Stage III periodontitis," you're past the subclinical window and into the territory of advanced periodontitis — a different management problem involving periodontal surgery, possible tooth extraction, and a periodontist rather than a general dentist.

If you mouth-breathe at night and wake with a dry mouth, look into night-time nasal breathing. Chronic mouth dryness accelerates plaque accumulation and gum inflammation in a way that the daily routine alone cannot fix.

If you have type 2 diabetes and your HbA_1c is above 8%, the gum-disease pathway is one of several non-medication moves that meaningfully shift the number — see the entries on type 2 diabetes management and glycemic control.

Tooth decay is a different disease with overlapping prevention (brushing helps both), different bacteria, different risk factors, and different treatment.

Cavity-driven bad breath, tongue-coating halitosis, and sinus drainage can all produce the morning-breath signature without periodontitis being the cause; if your gums look pink and don't bleed but your breath still isn't right, those are the next leads.

Related in the handbook

Worsens / aggravates

— Smoking both fuels gum disease and hides its earliest sign, the bleeding, so smokers' gums fail quietly.
— Mouth breathing is an overlooked driver of gum inflammation — the dry upper-front gums are a classic sign.
— Vaping is an under-noticed driver of quiet gum inflammation — milder than cigarettes, still a hit your dentist can see.

Helps

— Cleaning between the teeth is the single move that reverses early gum disease — bleeding stops in two weeks.
— A better brush is part of the cheap daily routine that clears most of what the average adult is carrying.
— An antiseptic rinse targets the gum bugs — useful short-term, though it also hits the good blood-pressure ones.
— Oil pulling offers a minor gum-health bump, but it's an add-on to the fundamentals, not a treatment for gum disease on its own.

— A spit test can flag the bacteria behind your bleeding gums, but a dental cleaning does far more than the report ever will.
— In diabetics, treating gum disease drops HbA1c about as much as adding a second pill — the link runs both ways.
— Routine dental imaging is part of how silent gum disease gets found before it costs you teeth.
— Bleeding gums aren't always plaque; a vitamin-C shortfall is a quieter cause worth ruling out.

Substance + claimed effects

Subclinical gum disease here means the spectrum of plaque-induced gingivitis (reversible inflammation of the gum margin — redness, swelling, bleeding on probing, no attachment loss) through early-stage periodontitis (Stage I and early Stage II under the 2018 AAP/EFP classification — interdental clinical attachment loss of 1–4 mm, probing pocket depths of 4–5 mm, mild-to-moderate radiographic bone loss) Tonetti et al. 2018 Chapple et al. 2018. The defining feature of the "subclinical" framing is that the patient typically does not perceive it as a disease: gums bleed occasionally on brushing or flossing, breath is mildly off, occasional gum tenderness — symptoms ascribed to "brushing too hard" or normal aging. By the time pain, mobility, or visible recession appear, the disease has typically progressed past Stage II. The entry covers the disease state itself, its epidemiology (prevalence, undertreatment, undertesting), its biological signature (subgingival dysbiotic biofilm, chronic low-grade systemic inflammation, intermittent bacteremia), recognized systemic associations (atherosclerotic cardiovascular disease, type 2 diabetes glycemic control, adverse pregnancy outcomes, rheumatoid arthritis, Alzheimer's disease and dementia, all-cause mortality), the diagnostic path (periodontal pocket-depth charting, bleeding on probing, bitewing radiographs), and the management toolkit (daily mechanical biofilm disruption with brushing and interdental cleaning, professional cleaning, scaling and root planing for established periodontitis, smoking cessation, glycemic control). Scoring is holistic across these consequences.

Evidence by addressing question

Mechanism

The biofilm-host response loop. Plaque-induced gingivitis is the most reliably reproducible inflammatory disease in humans. Loe's classic experimental-gingivitis model showed that withholding oral hygiene in healthy volunteers produces clinically detectable gingival inflammation in 10–21 days, with full reversal within a week of resumed cleaning Loe et al. 1965. The proximate cause is bacterial plaque accumulating at and below the gingival margin; the host responds with neutrophil infiltration, vasodilation, and crevicular fluid exudation. In a subset of susceptible individuals, the biofilm composition shifts toward Gram-negative anaerobes (the "red complex" — Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola — plus other dysbiotic species), and the host response shifts from contained gingivitis to bone-loss-producing periodontitis. The transition is not monotonic with biofilm volume; host immune phenotype, smoking status, glycemic control, and genetics all gate the conversion Chapple et al. 2018.

The three injury pathways producing systemic effects. A periodontal pocket lined with ulcerated epithelium adjacent to a dysbiotic biofilm creates a chronic open wound — for moderate periodontitis the total ulcerated surface across all pockets has been estimated at 8–20 cm², comparable in area to the palm of the hand. From that wound, three pathogenic streams flow into the rest of the body. (1) Direct bacteremia: oral organisms enter the circulation during routine activities — tooth brushing, flossing, chewing — and have been recovered from blood cultures and from atherosclerotic plaques. (2) Endotoxemia and cytokine spillover: bacterial lipopolysaccharide and locally produced IL-6, IL-1β, TNF-α, and CRP enter the systemic circulation, driving the liver's acute-phase response and chronic low-grade systemic inflammation. (3) Antigen mimicry and citrullination: P. gingivalis uniquely among prokaryotes expresses a peptidylarginine deiminase (PPAD) that citrullinates host proteins (fibrinogen, α-enolase), generating epitopes implicated in the breakdown of self-tolerance in rheumatoid arthritis Wegner et al. 2010 Schenkein et al. 2020.

Endothelial dysfunction as the bridge to cardiovascular outcomes. The strongest mechanistic link to atherosclerosis is via endothelial dysfunction. The Tonetti NEJM trial in 120 patients with severe periodontitis showed that intensive periodontal treatment produced an acute (24-hour) worsening of brachial-artery flow-mediated dilatation (FMD) paired with spikes in CRP, IL-6, E-selectin, and von Willebrand factor — followed by significant improvement in FMD and reductions in soluble E-selectin at 60 and 180 days. The biphasic response is direct evidence that periodontal inflammation produces, and treatment improves, endothelial function Tonetti et al. 2007.

Bidirectional metabolic loop with type 2 diabetes. The diabetes link runs both directions: hyperglycemia drives accumulation of advanced glycation end-products (AGEs) in periodontal tissues, exaggerates neutrophil hyper-responsiveness, and amplifies periodontal destruction; conversely, the systemic inflammatory load from periodontitis (elevated IL-6, TNF-α, CRP) reduces insulin sensitivity at the hepatic and muscle levels and worsens glycemic control Sanz et al. 2018.

Evidence

Prevalence. The 2009–2014 NHANES surveillance, using full-mouth six-site probing in a nationally representative US sample, found that 42% of US adults aged 30 and older had some form of periodontitis using the CDC/AAP case definition; 7.8% had severe periodontitis. Gingivitis was not separately quantified in that surveillance round, but earlier NHANES rounds put bleeding-on-probing-positive sites at roughly half of all adults Eke et al. 2018. The Global Burden of Disease 2010 meta-regression by Kassebaum put age-standardized prevalence of severe periodontitis at 11.2% worldwide — the sixth most common chronic disease globally, affecting ~743 million people; mild and moderate forms add another 30–40 percentage points on top depending on the case definition used Kassebaum et al. 2014. The reader-relevant headline: an adult walking into a dental office has odds approaching a coin flip of carrying some form of clinically detectable gum disease, and a one-in-ten chance of carrying the severe form.

Cardiovascular disease. The Larvin 2021 systematic review and meta-analysis pooled 11 prospective cohort studies (over 850,000 participants) and found a 22% increased risk of incident cardiovascular disease in adults with periodontal disease vs. those without (RR 1.22; 95% CI 1.14–1.30) Larvin et al. 2021. A 2023 39-cohort meta-analysis of over 4 million participants found similar magnitudes: RR 1.20 for coronary heart disease, RR 1.26 for stroke, RR 1.42 for cardiac death. The EFP/WHF 2020 consensus formalized the association: there is strong epidemiologic evidence that periodontitis is independently associated with atherosclerotic CVD; the mechanistic pathway through systemic inflammation and direct bacteremia is plausible; and treatment of periodontitis produces measurable improvements in surrogate endpoints (endothelial function, CRP, BP) Sanz et al. 2020. The consensus stops short of declaring periodontal treatment proven to prevent hard CV events — no adequately powered RCT exists for that endpoint.

Type 2 diabetes glycemic control. The link here has the strongest RCT-grade evidence among the systemic associations. Multiple systematic reviews of randomized periodontal-treatment trials in adults with type 2 diabetes converge on an HbA1c reduction of roughly 0.3–0.5 percentage points at 3–6 months — comparable to adding a second oral glucose-lowering agent. The D'Aiuto 2018 Lancet Diabetes & Endocrinology RCT (264 adults with type 2 diabetes and moderate-to-severe periodontitis, randomized to intensive vs. conventional periodontal therapy) found a 12-month HbA1c difference of 0.6 percentage points in favor of intensive treatment, with parallel improvements in markers of endothelial function and systemic inflammation D'Aiuto et al. 2018. The 2018 EFP/IDF consensus formalized the bidirectional relationship and now recommends periodontal screening as part of routine diabetes care Sanz et al. 2018.

Adverse pregnancy outcomes. Pregnant women with periodontitis have approximately 1.7–1.9 times higher odds of preterm birth and roughly 1.8 times higher odds of low birthweight compared with periodontally healthy controls in meta-analytic pooling of case-control and cohort studies Daalderop et al. 2018. Periodontal pathogens including Fusobacterium nucleatum have been recovered from amniotic fluid, placenta, and chorioamniotic membranes in cases of adverse pregnancy outcomes. Treatment trials of scaling and root planing during pregnancy have largely failed to show a reduction in preterm-birth rates (RR 0.90 in meta-analysis), suggesting that periodontal damage prior to conception, or unmeasured confounders, dominate the association.

Rheumatoid arthritis. P. gingivalis-induced citrullination of host proteins is one of the most-discussed candidate mechanisms for the breakdown of self-tolerance to citrullinated peptides — the autoimmune signature of RA. P. gingivalis is the only known prokaryote with a peptidylarginine deiminase, and antibodies to citrullinated P. gingivalis-derived peptides are detectable years before the clinical onset of RA Wegner et al. 2010. Epidemiologic association of periodontitis with prevalent and incident RA is consistent; causal contribution to RA onset remains an active hypothesis.

Alzheimer's disease and cognitive decline. The Asher 2022 meta-analysis of longitudinal studies (47 studies, mostly cohort) found that periodontitis was associated with a 23% increased risk of cognitive decline and a 21% increased risk of dementia, with severity dose-response (severe periodontitis HR ~1.5 for incident dementia) Asher et al. 2022. The Dominy 2019 Science Advances paper provided the keystone mechanistic finding: P. gingivalis DNA and its gingipain proteases were detected in postmortem Alzheimer's disease brains and correlated with tau pathology; oral infection of mice produced brain colonization, amyloid-β1–42 production, and neurodegeneration that was rescued by small-molecule gingipain inhibitors Dominy et al. 2019. The clinical translation has been disappointing — the Phase 2/3 GAIN trial of atuzaginstat, a gingipain inhibitor, failed its co-primary cognitive endpoints in 643 mild-to-moderate Alzheimer's patients overall, though a prespecified subgroup with P. gingivalis DNA detectable in saliva at baseline showed a 57% slowing of cognitive decline at the 80 mg dose; the program was halted on FDA hepatotoxicity concerns Detke et al. 2023. The mechanism remains live; the therapeutic story is unfinished.

All-cause mortality. The Larvin 2024 prospective cohort analysis in 15,030 US adults from NHANES followed for a median of 9 years found a 22% elevation in all-cause mortality risk in adults with periodontal disease vs. those without, with a clear dose-response: mild/moderate periodontitis carried a 4% elevation while severe periodontitis carried a ~40% elevation. Cardiovascular, respiratory, and diabetes mortality showed the largest severity-stratified gradients Larvin et al. 2024.

Treatment effects on systemic biomarkers. Meta-analyses of RCTs of non-surgical periodontal treatment show consistent reductions in hsCRP (pooled mean difference roughly −0.5 mg/L) and IL-6 at 3–6 months, larger in patients with established cardiovascular disease or diabetes. The Tonetti 2007 NEJM RCT showed improvements in brachial-artery flow-mediated dilatation at 6 months following intensive treatment, despite an acute worsening at 24 hours from treatment-induced bacteremia Tonetti et al. 2007.

Protocol

Daily mechanical biofilm disruption. Twice-daily brushing for two minutes with a fluoride toothpaste is the universal recommendation across every dental association. The Cochrane review of powered vs. manual toothbrushes (56 RCTs, 5,068 participants) found that rotating-oscillating powered brushes provided roughly 21% greater plaque reduction and 11% greater gingivitis reduction vs. manual at >3 months — modest but statistically robust effects favoring powered brushes Yaacob et al. 2014. Interdental cleaning (floss, interdental brushes, water flossers) is the second pillar; the Worthington 2019 Cochrane review found low-quality evidence that flossing reduces short-term gingivitis vs. brushing alone, with interdental brushes possibly more effective than floss; no high-quality evidence that any of these tools prevents periodontitis (because no RCT has run long enough) Worthington et al. 2019. The honest reading: the disease etiology (plaque accumulation, especially interproximally) makes interdental cleaning mechanistically required even though the long-term RCT base is thin.

Professional cleaning cadence. Standard recommendation is twice-yearly prophylaxis for periodontally healthy adults, escalating to 3–4 times yearly for adults with prior periodontitis, smokers, diabetics, or those with active gingivitis. Evidence for the universal twice-yearly schedule comes from clinical custom more than from cleanly designed RCTs.

Scaling and root planing for established periodontitis. The ADA 2015 evidence-based guideline meta-analyzed 72 trials of SRP and found an average improvement in clinical attachment level of ~0.5 mm, with adjuncts (locally delivered antimicrobials, systemic antibiotics, subantimicrobial-dose doxycycline) producing an additional 0.2–0.6 mm Smiley et al. 2015. SRP is the first-line intervention for Stage I–III periodontitis; periodontal surgery is reserved for residual deep pockets after non-surgical therapy.

Modifiable risk factor management. Smoking cessation is the single highest-yield modifiable risk factor — the Tomar NHANES III analysis attributed 42% of US periodontitis cases to current smoking and another 11% to former smoking; among current smokers, 75% of their periodontitis was smoking-attributable; risk declines toward baseline ~11 years after quitting Tomar et al. 2000. Glycemic control: patients with HbA1c >8% have markedly worse periodontal outcomes and respond more poorly to SRP than those with HbA1c <7%; treating periodontitis improves HbA1c by 0.3–0.5 points on average Sanz et al. 2018.

Stakes

The felt-experience signature of subclinical gum disease is silence: occasional pink in the sink when brushing, breath that the reader masks rather than addresses, gums that look slightly puffy in close mirror inspection but never produce pain. Over years to decades, untreated early periodontitis progresses to moderate and severe forms with attachment loss, gum recession (the "long-in-the-tooth" appearance), tooth mobility, and tooth loss; severe untreated periodontitis is the leading cause of tooth loss in adults globally and the dominant contributor to global edentulism in older adults. Systemically, the trajectory bends into the cardiovascular columns over decades: a ~20% baseline elevation in incident CVD and a ~40% elevation in all-cause mortality at the severe end of the disease spectrum Larvin et al. 2021 Larvin et al. 2024. For diabetics, glycemic control worsens by 0.3–0.5 HbA1c points; for pregnant women, preterm-birth and low-birthweight odds rise; for adults aging into the dementia-risk window, a 20–30% elevation in incident dementia risk lurks at the severe end of the spectrum Asher et al. 2022. None of these are dramatic in any given year. The trick of the disease is that the felt cost is small while the cumulative cost is large.

Payoff

Gingivitis is the most reliably reversible inflammatory disease in medicine. Loe's experimental-gingivitis model demonstrated full clinical resolution within a week of resumed oral hygiene Loe et al. 1965. The lived-experience version: stop ignoring the floss, brush properly for two minutes twice a day, and by week two the bleeding stops, the gums shrink back to a pale-pink margin, and the morning breath is markedly cleaner. Patients report partners stop commenting on bad breath; close-up photos look noticeably different. Early periodontitis treated by SRP yields measurable attachment-level improvement at 3–6 months, with the felt benefit being reduced gum tenderness, less bleeding, less halitosis. The systemic dividends — modest HbA1c improvement in diabetics, lower hsCRP, improved endothelial function, possibly reduced incident CVD and mortality over decades — compound silently. The "I haven't felt this clean in years" report and partner-side observations of better breath are the early felt-signal payoffs.

Misconceptions

"Bleeding gums mean you're brushing too hard." Bleeding from brushing or flossing is the cardinal sign of gingivitis — an inflamed, ulcerated gingival sulcus is what bleeds; healthy gums do not bleed on routine cleaning. The right response is more thorough cleaning, not less.

"If it doesn't hurt, it's fine." Periodontitis is largely painless until late stages. Early-to-moderate disease produces no pain signal because the chronic inflammation isn't acute and the periodontal ligament receives nociception only when actively inflamed or when teeth become mobile. Most adults discover their periodontitis from a routine probing exam, not from symptoms.

"Flossing doesn't work — even Cochrane said so." The Cochrane review found the evidence base for flossing's long-term effect on periodontitis is weak because no high-quality long-term RCT has been done; what evidence exists shows short-term gingivitis reduction Worthington et al. 2019. Mechanistically, interproximal plaque is unreachable by a toothbrush bristle and is the primary site of interproximal periodontitis. The absence of long-term RCT evidence is not evidence of absence.

"Brushing harder is cleaner." The opposite: aggressive brushing with a hard-bristled brush produces gingival recession and tooth-surface abrasion without removing plaque more effectively than gentle brushing with a soft brush. Soft bristles, light pressure, and time-over-pressure is the standard recommendation.

"Mouthwash replaces flossing." Antimicrobial mouthwash (chlorhexidine) reduces plaque chemically but does not remove established subgingival biofilm; it is an adjunct, not a replacement, for mechanical cleaning. Chronic chlorhexidine use also stains teeth and disrupts the oral microbiome.

"It's just an oral issue." The systemic-disease literature — cardiovascular, diabetes, pregnancy, dementia, mortality — is one of the most replicated cross-organ associations in medicine. Whether causal in every case is debated; that the association is real and clinically meaningful is not.

Failure modes

Asymptomatic acceptance. The single biggest failure mode is the reader assuming the absence of pain means absence of disease. Adults can carry stage II–III periodontitis for a decade with no symptom other than occasional bleeding on flossing.

Dental-visit avoidance. Cost, fear, or schedule friction keeps a meaningful fraction of US adults out of dental offices for years; periodontal probing depths are only measured at dental visits, so the disease goes undetected entirely. Eke 2018 NHANES showed that adults who hadn't visited a dentist in the prior year had periodontitis prevalence above 54% Eke et al. 2018.

Brushing without interdental cleaning. Toothbrush bristles do not reach interproximal contact areas. Adults who brush twice a day but never floss accumulate interproximal plaque and bone loss at sites the brush never touched.

SRP without behavior change. Scaling and root planing improves periodontal status at 3–6 months; without subsequent behavior change (daily mechanical cleaning, smoking cessation, maintenance prophylaxis every 3–4 months), pockets re-colonize within months. The intervention is the foundation, not the cure.

Smoking continues. Smoking is the single largest modifiable risk factor; smokers respond poorly to SRP, and their periodontitis trajectory progresses even with good home care. Periodontal therapy in active smokers without cessation is largely palliative Tomar et al. 2000.

Practicalities

Daily home care: a soft-bristled toothbrush ($3–10) or an entry-level rotating-oscillating electric ($30–200, replacement heads $20–40/year), fluoride toothpaste, and interdental cleaning tools (floss $5/year, interdental brushes $20–40/year, water flosser $50–100 one-time). Total annual home-care cost: $50–200 depending on tools chosen. Professional preventive visits in the US: $75–200 per cleaning twice yearly; insurance typically covers preventive visits in full or with small co-pay. Periodontal therapy: a single quadrant of scaling and root planing runs $200–400; a full-mouth four-quadrant treatment $800–1,500. Insurance coverage is partial — most dental plans pay 50–80% of perio therapy with annual caps that the full-mouth treatment can exceed. Periodontal surgery (flap surgery, bone grafting, guided tissue regeneration) ranges from $1,000 to $3,000 per quadrant. The friction is rarely the daily cost — floss is cheap — it's the time-and-routine cost of integrating interdental cleaning into a daily schedule, plus the dental-visit cadence that many adults let slip.

Audience

Two sub-populations warrant flagging. (1) Pregnant women: the link to preterm birth and low birthweight is the main reason periodontal screening is now recommended early in prenatal care; SRP during pregnancy is safe but the evidence for treatment reducing preterm birth is weak (suggesting prevention before conception matters more than treatment during pregnancy) Daalderop et al. 2018. (2) Type 2 diabetics: the bidirectional link makes routine periodontal exam part of diabetes care; treating periodontitis produces an HbA1c reduction comparable to adding a glucose-lowering medication Sanz et al. 2018 D'Aiuto et al. 2018. Adults with prior or active cardiovascular disease also benefit disproportionately from periodontal care given the endothelial-dysfunction mechanism. Older adults (60+) face higher prevalence, more frequent severe disease, and dementia-link concerns.

Contraindications

Daily home care is universally safe. Professional periodontal therapy has narrow contraindications: patients on anticoagulants or antiplatelet agents need coordination with the prescriber for invasive procedures (deep SRP, surgery); patients with prosthetic joints or specific high-risk cardiac conditions occasionally require antibiotic prophylaxis pre-procedure per AHA guidance (this has narrowed substantially since the 2007 AHA revision); patients on bisphosphonates or anti-resorptive cancer therapy carry a small risk of medication-related osteonecrosis of the jaw with invasive periodontal procedures. None of these contraindicate the entry's core action (daily oral hygiene + periodontal exam).

Out of scope

Dental caries and root caries (separate disease process, separate prevention path). Severe Stage III/IV periodontitis with mobility and tooth loss (separate clinical-management entry). Endodontic infections (root-canal pathology). Bruxism and TMJ disorders. Aggressive periodontitis (rare juvenile form, now reclassified). Oral cancer screening. Halitosis from non-periodontal causes (tongue coating, sinus drainage, GI sources). Mouth tape / nasal breathing (separate entry; some overlap via dry-mouth-driven plaque acceleration).

Credibility range

Optimist case

Subclinical gum disease is among the most underappreciated chronic-inflammation drivers in adults. Roughly 42% of US adults aged 30+ carry it, the substantial majority undetected and untreated Eke et al. 2018. The intervention is cheap, daily, mostly behavioral (brush properly, clean between teeth, see a hygienist twice a year), and reverses gingivitis fully within weeks Loe et al. 1965. Treatment produces measurable improvements in markers of systemic inflammation (hsCRP, IL-6), in endothelial function Tonetti et al. 2007, in glycemic control in diabetics D'Aiuto et al. 2018, and is associated with reduced incidence of cardiovascular events Larvin et al. 2021 and all-cause mortality Larvin et al. 2024. The mechanistic plausibility is strong: a chronic open wound 8–20 cm² in area, dysbiotic-biofilm-driven, with documented bacteremia from daily activities, is exactly the kind of low-grade systemic inflammation that drives atherosclerosis and metabolic dysregulation. The Alzheimer's connection through P. gingivalis brain invasion is one of the most provocative microbiome-CNS findings of the last decade Dominy et al. 2019. Every adult should treat their gums as a vital organ with measurable systemic consequences.

Skeptic case

The cardiovascular and dementia associations are observational and confounded. The same demographic profile that develops periodontitis — lower socioeconomic status, smoking, poor diet, infrequent medical care — also develops cardiovascular disease and dementia for independent reasons. Statistical adjustment is imperfect; residual confounding is large. The single RCT of periodontal treatment for cardiovascular event prevention has never been adequately powered or run. The Cochrane review of flossing for periodontitis prevention found the long-term RCT evidence essentially absent Worthington et al. 2019. The Tonetti NEJM finding of improved endothelial function at 6 months is a surrogate, not a clinical event. The atuzaginstat GAIN trial — the most direct test of the P. gingivalis → Alzheimer's hypothesis — failed its primary endpoints overall, surviving only as a subgroup signal Detke et al. 2023. The HbA1c reduction from periodontal therapy is real but modest (0.3–0.5 points) and short-duration (3–12 months); whether it persists or translates into reduced diabetes complications is unproven. The dental-industry incentive to promote systemic-disease links is large.

Author's call

The entry lands strongly on the take-it-seriously side, while being explicit about which claims have what level of evidence. The disease itself is real, common, and undertreated — that's not in dispute. Gingivitis is fully reversible, periodontitis is largely treatable, and the home-care cost is trivial relative to the downstream burden, so the action recommendation is robust even setting aside the systemic-disease story. The systemic-disease story itself: glycemic control in diabetics has the strongest RCT support and the most actionable clinical implication; cardiovascular association is well-replicated observationally with plausible mechanism but lacks RCT confirmation for hard endpoints; pregnancy, RA, and dementia associations are real but smaller and partially confounded. Evidence rates 4 (multiple meta-analyses, AAP/EFP/AHA consensus guidelines, large NHANES cohort, mechanistic RCTs on surrogates; mixed RCT data on hard endpoints). Controversy rates 2 (strong consensus on disease, prevalence, treatment effects; live debate on causality for hard cardiovascular/dementia endpoints and on flossing's long-term effect).

Stakeholder + incentive map

American Academy of Periodontology / European Federation of Periodontology / International Diabetes Federation: drove the 2018 classification system and the 2018/2020 systemic-disease consensus reports; aligned with screening and treatment expansion; commercial neutral but professional-prestige aligned with promoting the perio-systemic link.
General dentistry (ADA): commercial incentive to expand periodontal-therapy billing; produced the 2015 SRP guideline that is the standard reference; preventive-care cadence (twice-yearly visits) is partly evidence, partly clinical custom.
Oral-care product industry (Procter & Gamble, Colgate, Philips Sonicare, Oral-B, Waterpik): commercial incentive to push electric brushes, interdental tools, antimicrobial rinses. The Cochrane review's modest electric-vs-manual finding is industry-friendly; the flossing-evidence ambiguity is industry-uncomfortable and downplayed in marketing.
Diabetes care (ADA, IDF): increasingly aligned with periodontal screening in diabetes care after the 2018 EFP/IDF consensus.
Cardiology (AHA): historically conservative on declaring periodontitis a CVD risk factor; the 2020 EFP/WHF consensus moved the needle; AHA scientific statement (Lockhart 2012) recognized the association but stopped short of causal language.
Skeptic camp: evidence-based-medicine voices (notably Cochrane and several editorialists) push back on the systemic-disease causal framing as confounded; the AP "flossing doesn't work" news cycle (2016) crystallized public skepticism.
Insurance (US dental + medical): the dental/medical insurance split places systemic-disease prevention via oral care in a coverage gap; some payers are beginning to cover periodontal care for diabetics and pregnant patients under medical-benefit pilots.

Population variability

Age. Prevalence rises monotonically through middle age; severe periodontitis prevalence in NHANES was 9.8% in adults 45–64 and 17.2% in adults 65+ Eke et al. 2018.
Sex. Men have ~50–100% higher prevalence than women across most cohorts, partly explained by oral-hygiene behavior and smoking.
Socioeconomic status. Inverse gradient: lower income and education, higher prevalence; uninsured adults have markedly higher rates due to dental-visit avoidance.
Smoking. The single largest modifiable risk factor; 75% of periodontitis in current smokers is smoking-attributable Tomar et al. 2000.
Diabetes. 2–3× elevation in periodontitis prevalence and severity in poorly controlled diabetics; the relationship is bidirectional Sanz et al. 2018.
Pregnancy. Gingivitis prevalence is elevated 2–3× in pregnancy due to hormonal modulation of the gingival vascular and immune response; reversible postpartum unless underlying periodontitis is present.
Stress / allostatic load. Chronic stress and poor sleep are associated with worse periodontal outcomes through cortisol-driven immune dysregulation and behavioral pathways Sabbah et al. 2018.
Genetics. Twin studies estimate ~50% heritability of periodontitis susceptibility; specific IL-1 polymorphisms are associated with severity in some cohorts but are not used clinically.

Knowledge gaps

No adequately powered RCT of periodontal treatment for primary prevention of cardiovascular events. The strongest endpoint evidence is on surrogates (endothelial function, hsCRP, BP) and observational cohorts.
Long-term RCT evidence for flossing or interdental brushes on periodontitis incidence (as opposed to gingivitis) is essentially absent; the recommendation rests on mechanism and short-term gingivitis data Worthington et al. 2019.
Causal contribution of P. gingivalis to Alzheimer's disease pathology remains unconfirmed at the clinical-trial level after the atuzaginstat GAIN trial failure; subgroup signal is hypothesis-generating only Detke et al. 2023.
Whether SRP during pregnancy reduces preterm-birth risk — multiple negative RCTs suggest pre-conception periodontal status matters more than mid-pregnancy treatment.
Optimal recall intervals (the twice-yearly vs. three-monthly question for various risk strata) rest more on custom than on cleanly designed RCTs.
Long-term durability (>12 months) of HbA1c improvement from periodontal therapy in diabetics; most trials end at 6–12 months.
Whether routine periodontal screening in primary care or cardiology improves systemic outcomes — the implementation-research gap.

Scoping calls. The brief named gingivitis and early periodontitis in adults, plus prevalence, signs, and associations with CVD, diabetes, and other systemic conditions. All covered. Adverse pregnancy outcomes, RA, and dementia are folded into the evidence section as additional systemic associations beyond the named CVD/diabetes pair; this honors the brief's "and other systemic conditions" rather than narrowing it to the two named exemplars. Severe Stage III/IV periodontitis is explicitly out of scope — it's a different management problem and a different reader (post-diagnosis, in periodontist care).

Excluded topics, with reasons.

Advanced periodontitis (Stage III/IV) — separate entry candidate; the reader is downstream of diagnosis, the treatment menu shifts to surgery and tooth replacement. Flagged in out-of-scope.
Dental caries / tooth decay — overlapping prevention but a different disease (different bacteria, different mechanism, different management). Separate entry.
Dry mouth / xerostomia — relevant risk factor but its own management problem.
Pediatric and aggressive periodontitis — the rare juvenile/aggressive form (now reclassified as Stage IV Grade C) is out of scope; the entry is anchored on the typical adult presentation.
Halitosis from non-periodontal causes — pointed at in out-of-scope; not the entry's job.

Hard rating decisions.

Longevity 3 (not 4) — the all-cause mortality and CVD signals are real (Larvin 2021, Larvin 2024) and the dose-response with severity is clean, but the primary-prevention RCT for hard CV endpoints does not exist. Holding at 3 honors the observational signal without overstating it; 4 would imply the kind of intervention-grade evidence we have for, say, statin therapy.
Energy / Focus / Sleep / Mood 0 — resisted the temptation to score these non-zero on chronic-inflammation grounds. There's no clean primary literature on subjective energy or cognition rebounding after periodontal therapy in non-diabetic adults; the dementia association is captured under longevity. Scoring honestly per the "score 0 freely" guidance.
Beauty (direct) 2 / Beauty (cumulative) 3 — the cumulative score is higher because preventing the long-in-the-tooth recession profile across decades is the strongest aesthetic story; the direct score reflects the rapid bleeding/redness reversal but acknowledges that gingivitis resolution is mostly invisible at conversational distance.
Evidence 4 (not 5) — multiple consensus statements and meta-analyses, but the hard-CV-endpoint RCT is missing and the Cochrane on flossing remains weak. The strength-of-data call is real but not airtight.
Controversy 2 — live debates are narrow (causality for hard endpoints, flossing's long-term evidence, the P. gingivalis/Alzheimer's hypothesis after the atuzaginstat failure) but don't undermine the take-it-seriously case.
Action: do / Cadence: daily — debated against action: test (get a periodontal probing). Settled on do/daily because the reader's distinctive action is the home routine that runs daily for life; the periodontal exam is folded into the protocol callout rather than being the headline call.

Future links. Advanced periodontitis entry, dental caries entry, type 2 diabetes first-90-days (already exists — cross-link the diabetes/HbA1c paragraph), heart disease in women / cardiovascular-risk entries (mention the elevated CVD risk path), Alzheimer's / dementia entry, mouth-tape / nasal-breathing entry (already exists; cross-link out-of-scope), smoking entry (already exists; reinforces the cessation point).

Handling the Cochrane-on-flossing thing. The 2016 AP "flossing doesn't work" news cycle still sits in many readers' heads. Confronted directly in misconceptions; the article reframes Cochrane's actual finding ("no long-term trial has been run") rather than dismissing it. Readers who know the controversy will trust the entry more.

The atuzaginstat failure. The 2019 Dominy P. gingivalis in Alzheimer's brains finding is one of the most-cited oral-systemic papers of the decade and the GAIN trial failure complicates the story. Mentioned in evidence as "provocative but unfinished" rather than oversold or buried.

Tooth-loss aesthetics. Could have argued for a higher beauty_cumulative (4) on the "preventing edentulism = preventing the entire visible profile change of an aging mouth" basis. Held at 3 because the typical reader is decades from edentulism risk and the long-time-horizon trajectory of the cumulative axis is what it scores.